Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody designed to combat Zaire ebolavirus by binding to its surface glycoprotein. This binding action inhibits the viruss entry into host cells, effectively exhibiting antiviral activity
CAS Nummer:
[2375952-29-5]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
